ClinicalTrials.gov
ClinicalTrials.gov Menu

Exendin(9-39)Amide as a Glucagon-like Peptide-1 (GLP-1) Receptor Antagonist in Humans

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00393445
Recruitment Status : Completed
First Posted : October 27, 2006
Last Update Posted : October 4, 2011
Sponsor:
Collaborators:
German Research Foundation
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Joerg Schirra, Ludwig-Maximilians - University of Munich